Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares jumped over 25% yesterday, leaving investors underwhelmed. The drug maker reaffirmed its 2016 financial guidance of revenues ranging …
Horizon Pharma PLC (NASDAQ:HZNP) just roared through its second-quarter earnings results. For the quarter, the drug maker came in with $257.
Healthcare analysts are weighing in today on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Gilead Sciences, Inc. (NASDAQ:GILD).
Analysts were bullish on tech giant Apple Inc. (NASDAQ:AAPL) and entertainment giant Walt Disney Co (NYSE:DIS), following news coming from foreign markets that will help …
Valeant Pharmaceuticals Intl Inc Mizuho Securities analyst Irina Rivkind Koffler is one of Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s biggest bears, but she is also …
Analysts are weighing in today on two of the most talked-about stocks on Wall Street, drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and tech giant Apple Inc. (NASDAQ:AAPL).
Healthcare analysts expressed their opinions on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Depomed Inc (NASDAQ:DEPO) following a credit facility waiver and a battle …
Healthcare analysts provide insight on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with differing opinions.
Healthcare analysts from Mizuho and Rodman and Renshow explain their views on recent announcements made by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Synergy …
Healthcare analysts are chiming in today on drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Celgene Corporation (NASDAQ:CELG). The analysts reflect on Valeant’s disappointing earnings and Celgene’s recent price …